About this trial
The investigators will answer the question of whether treating insomnia using the mobile-app-based intervention of Cognitive Behavioural Therapy for Insomnia (CBT-I) for cancer survivors ("iCANSleep") can improve symptoms of insomnia in Canadian cancer survivors compared to a waitlist control group. The investigators will recruit 146 people with insomnia who have completed cancer treatment at least 3 months prior to the study.
Eligibility criteria
Qualifiers
Cancer survivors
Over 18 years of age
Lives in Canada
Understands English or French fluently
Disqualifiers
Presence of a sleep disorder other than insomnia that is not adequately treated (e.g., untreated sleep apnea)
Presence of a psychological disorder that is currently untreated or would impair the ability to participate (e.g., bipolar disorder)
Major sensory deficit (e.g., blindness)
Previous experience receiving CBT-I.
Trial design
Treatments tested in this trial
- App-Based Cognitive Behavioural Therapy for Insomnia